Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Q Fever Detected by Nucleic Acid Amplification

By LabMedica International staff writers
Posted on 28 May 2013
A Loop-Mediated Isothermal Amplification (LAMP) method has been developed for the detection of a specific gene of Coxiella burnetii, the causative agent of Q fever.

It is difficult to distinguish Q fever from other febrile diseases because of the lack of specific clinical manifestations in humans and conventional serodiagnosis requires sera from the acute and convalescent stages of infection, which are unavailable at early diagnosis. More...


Microbiologists from the Chinese Center for Disease Control and Prevention (Beijing, China) developed the LAMP method, which is a simple, rapid, specific, and cost-effective nucleic acid amplification technique. Between 2007 and 2012, they obtained 24 pairs of blood samples from the acute phase and convalescence of patients with clinical assessment of Q fever. The specificity of the LAMP assay was determined using a total of 42 strains, with 22 strains of the family Rickettsiales, four strains of Anaplasma phagocytophilum, and Ehrlichia chaffeenisis.

A set of universal primers against the repetitive sequence IS1111a of the transposase gene (htpAB) of C. burnetii was designed using PrimerExplorer V4 software and all LAMP reactions were performed with the Loopamp Kit (Eiken Chemical Co., Ltd.; Tokyo, Japan). The primers were based on conserved sequences and synthesized by Sangon Biotech (Shanghai, China). Before being used to determine the specificity of the LAMP assay, each bacterial DNA sample was first prescreened by polymerase chain reaction (PCR) using universal prokaryotic bacterial primers.

The LAMP assay was 100-fold more sensitive than conventional PCR at detecting C. burnetii and a positive result was obtained only for C. burnetii. When testing 24 blood samples from acute stage of clinical assessment Q fever patients, the scientists detected a total of eight positive results by the LAMP assay and two positives by real time PCR. This included five males, age range 29 to 56 years old and 19 females, ages range 16 to 69 years old.

The authors concluded that they had developed a rapid, simple, sensitive, and cost-effective LAMP assay to detect C. burnetii infection in human and domestic animals. Compared with the real time PCR developed in their laboratory, the LAMP assay is a potential tool to support the diagnosis of Q fever in humans and animals in the field, especially in the rural areas of China because of its rapid and sensitive detection without the aid of sophisticated equipment or complicated operations. The study was published on May 16, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Chinese Center for Disease Control and Prevention
Eiken Chemical Co., Ltd.
Sangon Biotech



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.